Adicet Begin Period Cash Flow vs Other Non Cash Items Analysis

ACET Stock

USD 0.91 0.01 1.09%

Adicet Bio financial indicator trend analysis is way more than just evaluating Adicet Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adicet Bio is a good investment. Please check the relationship between Adicet Bio Begin Period Cash Flow and its Other Non Cash Items accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.

Begin Period Cash Flow vs Other Non Cash Items

Begin Period Cash Flow vs Other Non Cash Items Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adicet Bio Begin Period Cash Flow account and Other Non Cash Items. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Adicet Bio's Begin Period Cash Flow and Other Non Cash Items is 0.5. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Adicet Bio, assuming nothing else is changed. The correlation between historical values of Adicet Bio's Begin Period Cash Flow and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Adicet Bio are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Begin Period Cash Flow i.e., Adicet Bio's Begin Period Cash Flow and Other Non Cash Items go up and down completely randomly.

Correlation Coefficient

0.5

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Other Non Cash Items

Most indicators from Adicet Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.51 in 2025, despite the fact that Enterprise Value is likely to grow to (62.7 M).

	2022	2023	2024	2025 (projected)
Interest Expense	80K	25K	28.8K	27.3K
Depreciation And Amortization	5.0M	6.1M	7.0M	5.2M

Interest Expense Depreciation And Amortization

Adicet Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Receivables	Non Currrent Assets Other	Short Term Debt
Total Assets		-0.11	0.87	0.81	0.4	0.02	-0.48	-0.12	0.51	0.72	0.05	0.93	-0.06	-0.06	0.07	-0.24	0.41	0.14	0.01	0.76	0.96	0.0	0.7	0.31	0.41	0.02
Short Long Term Debt Total	-0.11		-0.08	0.05	0.11	-0.46	-0.31	0.81	0.3	0.03	-0.31	0.02	-0.35	0.96	-0.16	0.84	0.66	-0.13	-0.43	0.14	-0.2	0.95	0.03	0.82	-0.88	0.57
Other Current Liab	0.87	-0.08		0.96	0.68	-0.19	-0.51	0.14	0.64	0.88	-0.32	0.92	-0.45	-0.07	-0.1	-0.23	0.53	0.22	-0.2	0.89	0.75	0.03	0.86	0.38	0.43	0.18
Total Current Liabilities	0.81	0.05	0.96		0.66	-0.39	-0.6	0.3	0.8	0.97	-0.46	0.87	-0.57	0.08	-0.23	-0.11	0.69	0.34	-0.41	0.91	0.7	0.17	0.96	0.53	0.3	0.33
Total Stockholder Equity	0.4	0.11	0.68	0.66		-0.29	-0.51	0.42	0.45	0.66	-0.52	0.51	-0.66	0.1	0.05	-0.1	0.56	0.24	-0.17	0.56	0.28	0.23	0.67	0.47	0.09	0.22
Property Plant And Equipment Net	0.02	-0.46	-0.19	-0.39	-0.29		0.11	-0.79	-0.81	-0.48	0.88	-0.09	0.71	-0.47	0.61	-0.38	-0.62	-0.3	0.94	-0.43	0.09	-0.46	-0.49	-0.58	0.26	-0.34
Current Deferred Revenue	-0.48	-0.31	-0.51	-0.6	-0.51	0.11		-0.24	-0.4	-0.63	0.07	-0.43	0.31	-0.37	-0.21	0.06	-0.75	-0.26	0.02	-0.37	-0.47	-0.49	-0.63	-0.62	0.24	-0.66
Net Debt	-0.12	0.81	0.14	0.3	0.42	-0.79	-0.24		0.6	0.33	-0.8	0.11	-0.79	0.76	-0.46	0.68	0.73	0.04	-0.77	0.37	-0.28	0.78	0.34	0.79	-0.6	0.54
Retained Earnings	0.51	0.3	0.64	0.8	0.45	-0.81	-0.4	0.6		0.85	-0.73	0.58	-0.71	0.35	-0.57	0.2	0.79	0.39	-0.82	0.77	0.41	0.38	0.86	0.67	0.01	0.38
Accounts Payable	0.72	0.03	0.88	0.97	0.66	-0.48	-0.63	0.33	0.85		-0.53	0.75	-0.63	0.07	-0.27	-0.14	0.73	0.49	-0.48	0.84	0.64	0.17	0.99	0.54	0.27	0.34
Cash	0.05	-0.31	-0.32	-0.46	-0.52	0.88	0.07	-0.8	-0.73	-0.53		-0.17	0.9	-0.29	0.6	-0.28	-0.55	-0.22	0.88	-0.49	0.21	-0.32	-0.55	-0.47	0.1	-0.31
Non Current Assets Total	0.93	0.02	0.92	0.87	0.51	-0.09	-0.43	0.11	0.58	0.75	-0.17		-0.3	0.06	-0.11	-0.05	0.5	-0.01	-0.15	0.87	0.8	0.12	0.74	0.41	0.34	0.11
Cash And Short Term Investments	-0.06	-0.35	-0.45	-0.57	-0.66	0.71	0.31	-0.79	-0.71	-0.63	0.9	-0.3		-0.31	0.62	-0.3	-0.67	-0.27	0.75	-0.55	0.12	-0.39	-0.65	-0.57	0.12	-0.45
Good Will	-0.06	0.96	-0.07	0.08	0.1	-0.47	-0.37	0.76	0.35	0.07	-0.29	0.06	-0.31		-0.14	0.83	0.71	-0.14	-0.41	0.07	-0.13	0.99	0.07	0.86	-0.9	0.65
Common Stock Shares Outstanding	0.07	-0.16	-0.1	-0.23	0.05	0.61	-0.21	-0.46	-0.57	-0.27	0.6	-0.11	0.62	-0.14		-0.4	-0.24	-0.2	0.77	-0.33	0.19	-0.11	-0.29	-0.19	-0.01	-0.14
Non Current Liabilities Total	-0.24	0.84	-0.23	-0.11	-0.1	-0.38	0.06	0.68	0.2	-0.14	-0.28	-0.05	-0.3	0.83	-0.4		0.43	-0.15	-0.46	-0.01	-0.36	0.78	-0.13	0.63	-0.78	0.38
Inventory	0.41	0.66	0.53	0.69	0.56	-0.62	-0.75	0.73	0.79	0.73	-0.55	0.5	-0.67	0.71	-0.24	0.43		0.29	-0.58	0.57	0.31	0.78	0.74	0.94	-0.45	0.71
Other Current Assets	0.14	-0.13	0.22	0.34	0.24	-0.3	-0.26	0.04	0.39	0.49	-0.22	-0.01	-0.27	-0.14	-0.2	-0.15	0.29		-0.26	0.19	0.24	-0.09	0.47	0.18	0.16	0.08
Other Stockholder Equity	0.01	-0.43	-0.2	-0.41	-0.17	0.94	0.02	-0.77	-0.82	-0.48	0.88	-0.15	0.75	-0.41	0.77	-0.46	-0.58	-0.26		-0.49	0.13	-0.4	-0.5	-0.52	0.19	-0.32
Total Liab	0.76	0.14	0.89	0.91	0.56	-0.43	-0.37	0.37	0.77	0.84	-0.49	0.87	-0.55	0.07	-0.33	-0.01	0.57	0.19	-0.49		0.62	0.13	0.83	0.46	0.33	0.12
Total Current Assets	0.96	-0.2	0.75	0.7	0.28	0.09	-0.47	-0.28	0.41	0.64	0.21	0.8	0.12	-0.13	0.19	-0.36	0.31	0.24	0.13	0.62		-0.09	0.62	0.22	0.43	-0.04
Intangible Assets	0.0	0.95	0.03	0.17	0.23	-0.46	-0.49	0.78	0.38	0.17	-0.32	0.12	-0.39	0.99	-0.11	0.78	0.78	-0.09	-0.4	0.13	-0.09		0.17	0.9	-0.88	0.7
Common Stock	0.7	0.03	0.86	0.96	0.67	-0.49	-0.63	0.34	0.86	0.99	-0.55	0.74	-0.65	0.07	-0.29	-0.13	0.74	0.47	-0.5	0.83	0.62	0.17		0.53	0.27	0.34
Net Receivables	0.31	0.82	0.38	0.53	0.47	-0.58	-0.62	0.79	0.67	0.54	-0.47	0.41	-0.57	0.86	-0.19	0.63	0.94	0.18	-0.52	0.46	0.22	0.9	0.53		-0.63	0.67
Non Currrent Assets Other	0.41	-0.88	0.43	0.3	0.09	0.26	0.24	-0.6	0.01	0.27	0.1	0.34	0.12	-0.9	-0.01	-0.78	-0.45	0.16	0.19	0.33	0.43	-0.88	0.27	-0.63		-0.58
Short Term Debt	0.02	0.57	0.18	0.33	0.22	-0.34	-0.66	0.54	0.38	0.34	-0.31	0.11	-0.45	0.65	-0.14	0.38	0.71	0.08	-0.32	0.12	-0.04	0.7	0.34	0.67	-0.58

Click cells to compare fundamentals

Adicet Bio Account Relationship Matchups

Adicet Bio fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	153.8M	338.9M	330.7M	207.3M	186.6M	215.3M
Short Long Term Debt Total	21.6M	20.9M	21.0M	20.9M	24.1M	22.9M
Other Current Liab	4.5M	5.1M	10.3M	13.4M	12.1M	18.5M
Total Current Liabilities	14.0M	16.3M	19.7M	19.3M	17.4M	16.5M
Total Stockholder Equity	(106.3M)	(168.3M)	(238.1M)	170.2M	153.2M	160.8M
Property Plant And Equipment Net	25.9M	35.0M	49.0M	44.2M	50.8M	53.4M
Net Debt	(62.7M)	(256.6M)	(236.6M)	(138.8M)	(124.9M)	(118.7M)
Retained Earnings	(106.3M)	(168.3M)	(238.1M)	(380.8M)	(342.7M)	(325.6M)
Accounts Payable	1.6M	3.3M	4.4M	2.6M	2.4M	2.2M
Cash	84.3M	277.5M	257.7M	159.7M	183.7M	192.9M
Non Current Assets Total	59.2M	56.5M	69.7M	45.0M	40.5M	58.4M
Cash And Short Term Investments	94.6M	277.5M	257.7M	159.7M	183.7M	95.6M
Common Stock Shares Outstanding	7.3M	31.0M	41.1M	43.0M	49.5M	28.0M
Liabilities And Stockholders Equity	153.8M	(132.5M)	(199.8M)	207.3M	186.6M	165.2M
Non Current Liabilities Total	246.2M	19.5M	18.6M	17.8M	20.5M	19.5M
Other Current Assets	5.6M	4.7M	2.9M	2.6M	2.3M	2.2M
Other Stockholder Equity	62.3M	471.4M	530.4M	550.9M	633.6M	665.3M
Total Liab	44.0M	35.8M	38.4M	37.1M	33.4M	31.7M
Total Current Assets	94.6M	282.4M	261.0M	162.3M	146.0M	156.9M
Non Currrent Assets Other	12.1M	2.0M	1.2M	822K	945.3K	992.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC